33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
6.15%
Cash & equivalents growing 6.15% while PATH's declined -8.30%. Peter Lynch would see this as a sign of superior liquidity management.
-14.58%
Short-term investments yoy growth below half of PATH's 10.66%. Michael Burry might see potential liquidity risk. Investigate alternative capital uses or constraints.
-8.97%
Cash + STI yoy ≥ 1.5x PATH's -0.68%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
-0.19%
Receivables growth less than half of PATH's 48.98%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
24.51%
Inventory growth above 1.5x PATH's 7.15%. Michael Burry might suspect a looming inventory glut. Check free cash flow impact.
19.71%
Above 1.5x PATH's 5.78%. Michael Burry might investigate for potential short-term asset misclassification or risk.
-3.79%
Below half of PATH's 5.47%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-5.93%
≥ 1.5x PATH's -1.69%. David Dodd sees more aggressive capex. Confirm it's not overspending.
No Data
No Data available this quarter, please select a different quarter.
15.98%
Less than half of PATH's -14.47%. David Dodd sees relatively fewer intangible expansions. Possibly more tangible-driven.
15.98%
Less than half of PATH's -5.07%. David Dodd sees fewer intangible expansions vs. competitor. Possibly safer balance sheet.
72.63%
≥ 1.5x PATH's 5.01%. David Dodd sees an aggressive push into LT investments. Confirm risk management.
-15.98%
Above 1.5x PATH's -7.72%. Michael Burry suspects major tax losses or deferrals building up, raising concerns about sustained profitability.
2.50%
Less than half of PATH's -25.13%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
12.16%
Below half of PATH's -2.49%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
2.66%
0.5-0.75x PATH's 4.38%. Martin Whitman worries about slower asset growth than competitor. Is it strategy or constraint?
10.35%
Less than half of PATH's 624.11%. David Dodd sees a more disciplined AP approach or lower volume.
24.65%
Higher Short-Term Debt Growth compared to PATH's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
5.33%
Similar yoy growth to PATH's 5.68%. Walter Schloss notes parallel approach to deferred revenue.
-4.96%
Less than half of PATH's 84.64%. David Dodd sees fewer expansions in other current obligations.
5.66%
Less than half of PATH's 21.14%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
6.32%
Below half PATH's 27.77%. Michael Burry suspects a serious gap in multi-year pipeline.
No Data
No Data available this quarter, please select a different quarter.
0.16%
Less than half of PATH's -3.43%. David Dodd notes more conservative expansions in non-current obligations.
0.90%
Less than half of PATH's 17.51%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
4.13%
Less than half of PATH's 20.25%. David Dodd sees far fewer liability expansions relative to competitor.
3.23%
Higher Common Stock (Book Value) Growth compared to PATH's zero value, indicating worse performance.
-3.51%
≥ 1.5x PATH's -1.65%. David Dodd sees higher yoy retained profits than competitor.
-43.76%
50-75% of PATH's -72.55%. Bruce Berkowitz notes relatively lower AOCI expansions.
No Data
No Data available this quarter, please select a different quarter.
1.56%
Below half PATH's -1.12%. Michael Burry sees potential underperformance in building shareholder capital.
2.66%
0.5-0.75x PATH's 4.38%. Martin Whitman sees underexpansion or possible missed opportunities.
0.40%
Below half PATH's 10.66%. Michael Burry suspects major underinvestment or forced divestment.
-1.91%
Less than half of PATH's 1.74%. David Dodd sees less overall debt expansion vs. competitor.
-15.62%
Less than half of PATH's 8.85%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
